BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20118404)

  • 1. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.
    Nurden P; Gobbi G; Nurden A; Enouf J; Youlyouz-Marfak I; Carubbi C; La Marca S; Punzo M; Baronciani L; De Marco L; Vitale M; Federici AB
    Blood; 2010 Apr; 115(13):2649-56. PubMed ID: 20118404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered megakaryocytopoiesis in von Willebrand type 2B disease.
    Nurden AT; Federici AB; Nurden P
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():277-81. PubMed ID: 19630816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
    Castaman G; Federici AB
    Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
    Nurden P; Debili N; Vainchenker W; Bobe R; Bredoux R; Corvazier E; Combrie R; Fressinaud E; Meyer D; Nurden AT; Enouf J
    Blood; 2006 Oct; 108(8):2587-95. PubMed ID: 16720832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.
    Casari C; Paul DS; Susen S; Lavenu-Bombled C; Harroche A; Piatt R; Poe KO; Lee RH; Bryckaert M; Christophe OD; Lenting PJ; Denis CV; Bergmeier W
    Blood Adv; 2018 Jun; 2(12):1417-1428. PubMed ID: 29925524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
    Kanaji S; Morodomi Y; Weiler H; Zarpellon A; Montgomery RR; Ruggeri ZM; Kanaji T
    Haematologica; 2022 Sep; 107(9):2133-2143. PubMed ID: 35142156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model.
    Poujol C; Ware J; Nieswandt B; Nurden AT; Nurden P
    Exp Hematol; 2002 Apr; 30(4):352-60. PubMed ID: 11937271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.
    Casari C; Berrou E; Lebret M; Adam F; Kauskot A; Bobe R; Desconclois C; Fressinaud E; Christophe OD; Lenting PJ; Rosa JP; Denis CV; Bryckaert M
    J Clin Invest; 2013 Dec; 123(12):5071-81. PubMed ID: 24270421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets.
    Schmitt A; Guichard J; Massé JM; Debili N; Cramer EM
    Exp Hematol; 2001 Nov; 29(11):1295-302. PubMed ID: 11698125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
    Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
    Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
    Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
    J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
    Frontroth JP; Favaloro EJ
    Methods Mol Biol; 2017; 1646():473-494. PubMed ID: 28804849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
    Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
    Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13.
    Ma Z; Su J; Zhang J; Ling J; Yin J; Bai X; Ruan C
    Thromb Res; 2015 Nov; 136(5):987-95. PubMed ID: 26345337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions.
    Golder M; Pruss CM; Hegadorn C; Mewburn J; Laverty K; Sponagle K; Lillicrap D
    Blood; 2010 Jun; 115(23):4862-9. PubMed ID: 20371742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
    Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
    J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.
    Woods AI; Kempfer AC; Paiva J; Sanchez-Luceros A; Bermejo E; Chuit R; Alberto MF; Blanco AN; Lazzari MA
    Semin Thromb Hemost; 2017 Feb; 43(1):92-100. PubMed ID: 27978591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.